SALLMAN, DAVID A.;LIST, ALAN F.;LIXTE BIOTECHNOLOGY, INC.
发明人:
LIST, ALAN F.,SALLMAN, DAVID A.,KOVACH, JOHN S.
申请号:
CA3051828
公开号:
CA3051828A1
申请日:
2017.01.27
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
This invention provides a method of treating myelodysplastic syndrome in a human subject afflicted therewith comprising administering to the subject an amount from 0.1 mg/m2 to 5 mg/m2 of a compound having the structure (I) or a salt, zwitterion, or ester thereof.